The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"

Assistance Publique - Hôpitaux de Paris

Status: Completed

Conditions: Hematological Malignancies

Study type: Observational

Funder types: Other

Identifiers

NCT01172132

AOM 08235

Details and patient eligibility

About

The purpose of this study is to determine:

• Condition of intensive care unit (ICU) admission in patients with haematological malignancies.
• ICU hospital and up to one year mortality.
• Assessment of post ICU burden and health related quality at 90-d and 1 year.

Full description

1. To identify prognostic factors of short and medium term mortality, by underlining the respective weights of organ dysfunction and characteristics of underlined malignancy
2. Evaluate the health related quality of life of intensive care survivors(SF36)
3. Impact of intensive care on families burden (HADS, IES).
4. Assess clinicians' satisfaction ( intensivists, haematologists and intensive care nurses) in relation to medical decision-making.
5. Establish the relevance of antifungal treatments.

Enrollment: 1,011 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hematological malignancies
• hospitalization in ICU
• age >= 18 years

Exclusion criteria

• Patients who have already participated to TRIAL-OH